460 related articles for article (PubMed ID: 7835781)
21. Endometrial pathology at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and nonusers.
Gibson LE; Barakat RR; Venkatraman ES; Hoskins WJ
Cancer J Sci Am; 1996; 2(1):35-8. PubMed ID: 9166496
[TBL] [Abstract][Full Text] [Related]
22. Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women.
Voipio SK; Komi J; Kangas L; Halonen K; DeGregorio MW; Erkkola RU
Maturitas; 2002 Nov; 43(3):207-14. PubMed ID: 12443837
[TBL] [Abstract][Full Text] [Related]
23. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.
Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F
Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait.
Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE
Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616
[TBL] [Abstract][Full Text] [Related]
25. Tamoxifen and endometrial cancer.
Segna RA; Dottino PR; Deligdisch L; Cohen CJ
Mt Sinai J Med; 1992 Oct; 59(5):416-8. PubMed ID: 1435840
[TBL] [Abstract][Full Text] [Related]
26. Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients.
Rose DP; Chlebowski RT; Connolly JM; Jones LA; Wynder EL
Cancer Res; 1992 Oct; 52(19):5386-90. PubMed ID: 1394142
[TBL] [Abstract][Full Text] [Related]
27. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)].
Ivanova V; Karaivanov M; Marinov E; Gorchev G; Velkova A; Khristova P
Akush Ginekol (Sofiia); 2003; 42(5):3-8. PubMed ID: 14682005
[TBL] [Abstract][Full Text] [Related]
28. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.
Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y
Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440
[TBL] [Abstract][Full Text] [Related]
29. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups.
Schlesinger C; Kamoi S; Ascher SM; Kendell M; Lage JM; Silverberg SG
Int J Gynecol Pathol; 1998 Oct; 17(4):302-11. PubMed ID: 9785130
[TBL] [Abstract][Full Text] [Related]
30. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
[TBL] [Abstract][Full Text] [Related]
31. Effects of tamoxifen therapy on the expression of p27 protein in the endometrium of women with primary breast cancer.
Siufi AA; Cotrim G Da Silva ID; De Cassia M Dardes R; Takita LC; Rodrigues De Lima G; Gonçalves WJ
Int J Oncol; 2003 Dec; 23(6):1545-51. PubMed ID: 14612925
[TBL] [Abstract][Full Text] [Related]
32. [Role of steroid hormones and related biological substances in the etiology of endometrial carcinomas].
Lang-Avérous G; Rupp K; Wehner H; Dallenbach-Hellweg G
Verh Dtsch Ges Pathol; 1991; 75():366-9. PubMed ID: 1724843
[TBL] [Abstract][Full Text] [Related]
33. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
[TBL] [Abstract][Full Text] [Related]
34. Ultrasonography of the endometrium and endometrial pathology under tamoxifen treatment.
Friedrich M; Villena-Heinsen C; Mink D; Endres V; Reitnauer K; Schmidt W
Eur J Gynaecol Oncol; 1998; 19(6):536-40. PubMed ID: 10215436
[TBL] [Abstract][Full Text] [Related]
35. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C
Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921
[TBL] [Abstract][Full Text] [Related]
36. Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: a double-blind, randomized trial.
Rutanen EM; Heikkinen J; Halonen K; Komi J; Lammintausta R; Ylikorkala O
Menopause; 2003; 10(5):433-9. PubMed ID: 14501605
[TBL] [Abstract][Full Text] [Related]
37. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
[TBL] [Abstract][Full Text] [Related]
38. [Cancer of the endometrium caused by antiestrogens].
Le Bouëdec G; Dauplat J
Rev Fr Gynecol Obstet; 1992 Jun; 87(6):345-8. PubMed ID: 1631476
[TBL] [Abstract][Full Text] [Related]
39. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.
Mourits MJ; Van der Zee AG; Willemse PH; Ten Hoor KA; Hollema H; De Vries EG
Gynecol Oncol; 1999 Apr; 73(1):21-6. PubMed ID: 10094875
[TBL] [Abstract][Full Text] [Related]
40. One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus.
Simon JA; Lin VH; Radovich C; Bachmann GA;
Menopause; 2013 Apr; 20(4):418-27. PubMed ID: 23096251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]